These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28245759)

  • 21. Modeling the interaction between dendrimers and nucleic acids: a molecular perspective through hierarchical scales.
    Pavan GM
    ChemMedChem; 2014 Dec; 9(12):2623-31. PubMed ID: 25209748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principal Physicochemical Methods Used to Characterize Dendrimer Molecule Complexes Used as Genetic Therapy Agents, Nanovaccines or Drug Carriers.
    Alberto RFR; Joao R; de Los Angeles MM; Alberto MM; Manuel Jonathan FV; José CB
    Curr Pharm Des; 2017 Aug; 23(21):3076-3083. PubMed ID: 28228073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(amidoamine)-based dendrimer/siRNA complexation studied by computer simulations: effects of pH and generation on dendrimer structure and siRNA binding.
    Karatasos K; Posocco P; Laurini E; Pricl S
    Macromol Biosci; 2012 Feb; 12(2):225-40. PubMed ID: 22147430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of novel, fluorescent, tagged glutamic acid dendrimers with different terminal groups and in silico analysis of their properties.
    Martinho N; Silva LC; Florindo HF; Brocchini S; Zloh M; Barata TS
    Int J Nanomedicine; 2017; 12():7053-7073. PubMed ID: 29026301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics simulations of polyamidoamine dendrimers and their complexes with linear poly(ethylene oxide) at different pH conditions: static properties and hydrogen bonding.
    Tanis I; Karatasos K
    Phys Chem Chem Phys; 2009 Nov; 11(43):10017-28. PubMed ID: 19865754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement.
    Gupta U; Agashe HB; Asthana A; Jain NK
    Biomacromolecules; 2006 Mar; 7(3):649-58. PubMed ID: 16529394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
    Patri AK; Kukowska-Latallo JF; Baker JR
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
    Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
    J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine.
    Mariyam M; Ghosal K; Thomas S; Kalarikkal N; Latha MS
    Mini Rev Med Chem; 2018 Feb; 18(5):439-457. PubMed ID: 28618985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.
    Cheng Y; Wang J; Rao T; He X; Xu T
    Front Biosci; 2008 Jan; 13():1447-71. PubMed ID: 17981642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-Assembly Behavior of Amphiphilic Janus Dendrimers in Water: A Combined Experimental and Coarse-Grained Molecular Dynamics Simulation Approach.
    Elizondo-García ME; Márquez-Miranda V; Araya-Durán I; Valencia-Gallegos JA; González-Nilo FD
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational investigations of a Peptide-modified dendrimer interacting with lipid membranes.
    Tu CK; Chen K; Tian WD; Ma YQ
    Macromol Rapid Commun; 2013 Aug; 34(15):1237-42. PubMed ID: 23836696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendrimers: emerging polymers for drug-delivery systems.
    Nanjwade BK; Bechra HM; Derkar GK; Manvi FV; Nanjwade VK
    Eur J Pharm Sci; 2009 Oct; 38(3):185-96. PubMed ID: 19646528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the role of surface chemistry on cationic phosphorus dendrimer-siRNA complexation.
    Deriu MA; Tsapis N; Noiray M; Grasso G; El Brahmi N; Mignani S; Majoral JP; Fattal E; Danani A
    Nanoscale; 2018 Jun; 10(23):10952-10962. PubMed ID: 29850714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of dendrimers with biological drug targets: reality or mystery - a gap in drug delivery and development research.
    Ahmed S; Vepuri SB; Kalhapure RS; Govender T
    Biomater Sci; 2016 Jul; 4(7):1032-50. PubMed ID: 27100841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendrimer nanocarriers as versatile vectors in gene delivery.
    Dutta T; Jain NK; McMillan NA; Parekh HS
    Nanomedicine; 2010 Feb; 6(1):25-34. PubMed ID: 19450708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes.
    Ledall J; Fruchon S; Garzoni M; Pavan GM; Caminade AM; Turrin CO; Blanzat M; Poupot R
    Nanoscale; 2015 Nov; 7(42):17672-84. PubMed ID: 26335052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern.
    Maingi V; Kumar MV; Maiti PK
    J Phys Chem B; 2012 Apr; 116(14):4370-6. PubMed ID: 22420638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer simulation of the structural properties of fatty-acid modified PAMAM dendrimers at pH 5 and 7.
    Tu CK; Mou W; Shen ZL
    J Mol Graph Model; 2023 Nov; 124():108570. PubMed ID: 37487373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.